
Certolizumab: Uses, Dosage, Side Effects, Warnings - Drugs.com
2024年12月9日 · Certolizumab pegol (brand name Cimzia) is an injectable TNF blocker that may be used to treat adults with Crohn's disease, rheumatoid arthritis, psoriatic arthritis, plaque psoriasis, ankylosing spondylitis, and non-radiographic axial spondyloarthritis.
Certolizumab pegol - Wikipedia
Certolizumab pegol, sold under the brand name Cimzia, is a biopharmaceutical medication for the treatment of Crohn's disease, [4] [5] rheumatoid arthritis, psoriatic arthritis and ankylosing spondylitis.
Certolizumab (Cimzia®) Drug Information Sheet
Certolizumab pegol is a drug that reduces the signs and symptoms of moderate to severe rheumatoid arthritis (RA), psoriatic arthritis (PsA), ankylosing spondylitis, and Crohn’s disease. It works to improve such symptoms as joint swelling, pain, fatigue, and morning stiffness.
CIMZIA® (certolizumab pegol) | An FDA-Approved Biologic …
CIMZIA is a prescription medicine called a Tumor Necrosis Factor (TNF) blocker that can lower the ability of your immune system to fight infections. Some people who received CIMZIA have developed serious infections, including tuberculosis (TB) and infections caused by viruses, fungi, or bacteria that have spread throughout the body.
Certolizumab (subcutaneous route) - Mayo Clinic
2025年2月1日 · Certolizumab injection is used to reduce the signs and symptoms of moderate to severe active Crohn disease in patients who have received other medicines or treatments that did not work well. Certolizumab injection is also used to treat moderate to …
Certolizumab: Arthritis Uses, Side Effects & Dosage - MedicineNet
2023年10月13日 · What is certolizumab, and what is it used for? Certolizumab is an injectable synthetic (man-made) protein antibody that binds to tumor necrosis factor alpha (TNFα) in the body and blocks the effects of TNFα in patients with rheumatoid arthritis and Crohn's disease.
Certolizumab - Rheumatology
What is certolizumab? Certolizumab belongs to a class of medications called biological disease modifying antirheumatic drugs (biological DMARDs or bDMARDs). Specifically, it is a TNF inhibitor. bDMARDs have now been given to over a million people worldwide since their first use in the late 1990s.
certolizumab pegol (Rx) - Medscape Drugs & Diseases
Medscape - Rheumatoid arthritis and Crohn disease dosing for Cimzia (certolizumab pegol) , frequency-based adverse effects, comprehensive interactions, contraindications, pregnancy & lactation...
Certolizumab Pegol: Side Effects, Uses, Dosage, Interactions ... - RxList
Certolizumab Pegol is a prescription medication used for treating the symptoms of Crohn’s disease, rheumatoid arthritis, psoriatic arthritis, ankylosing spondylitis, spondyloarthritis, and plaque psoriasis.
Cimzia: Side Effects, Dosage & Uses - Drugs.com
2024年12月9日 · Cimzia injection (certolizumab pegol) is used to treat Crohn's disease, rheumatoid arthritis, psoriatic arthritis, plaque psoriasis, ankylosing spondylitis and non-radiographic axial spondyloarthritis.